14-3-3 protein zeta/delta (1433Z) was discovered as a putative prognostic marker for renal cell carcinoma (Masui et al, 2013) and for monitoring chemotherapy in breast cancer (Hodgkinson et al, 2012). Here, YWHAZ is linked to renal cell carcinoma.